S. Muoio & CO. LLC purchased a new stake in Syneron Medical Ltd. (NASDAQ:ELOS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 260,000 shares of the medical equipment provider’s stock, valued at approximately $2,847,000. Syneron Medical comprises approximately 1.4% of S. Muoio & CO. LLC’s investment portfolio, making the stock its 22nd largest position.

Several other hedge funds also recently added to or reduced their stakes in the company. Citadel Advisors LLC increased its stake in shares of Syneron Medical by 2.1% in the first quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock worth $125,000 after buying an additional 243 shares in the last quarter. Brandes Investment Partners LP increased its stake in shares of Syneron Medical by 0.6% in the first quarter. Brandes Investment Partners LP now owns 3,680,764 shares of the medical equipment provider’s stock worth $38,832,000 after buying an additional 20,151 shares in the last quarter. Mizuho Securities USA LLC purchased a new stake in shares of Syneron Medical during the second quarter worth approximately $5,037,000. Acadian Asset Management LLC increased its stake in shares of Syneron Medical by 261.1% in the first quarter. Acadian Asset Management LLC now owns 1,146,905 shares of the medical equipment provider’s stock worth $12,098,000 after buying an additional 829,326 shares in the last quarter. Finally, Jane Street Group LLC increased its stake in shares of Syneron Medical by 117.9% in the first quarter. Jane Street Group LLC now owns 10,373 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 68,405 shares in the last quarter. Institutional investors own 69.17% of the company’s stock.

Syneron Medical Ltd. (ELOS) opened at 11.00 on Tuesday. Syneron Medical Ltd. has a one year low of $6.18 and a one year high of $11.43. The stock has a 50 day moving average price of $10.90 and a 200-day moving average price of $10.14.

TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/260000-shares-in-syneron-medical-ltd-elos-acquired-by-s-muoio-co-llc/1490892.html.

A number of analysts have commented on the company. BidaskClub downgraded Syneron Medical from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. Maxim Group downgraded Syneron Medical from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $12.00 to $11.00 in a research report on Friday, May 12th.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Want to see what other hedge funds are holding ELOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneron Medical Ltd. (NASDAQ:ELOS).

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.